[--------------- FORM 8-K CURRENT REPORTte of Report (Date of earliest event reported): December 22, 2010 CHINA PHARMAS, --------------------------------------- Delaware 001-34471 73-1564807 (State or other jurisdiction (Commission File No.) (IRS Employer oforporation) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China570216 +86 898-6681-1730 Item 5.07.Submission of Matters to a Vote of Security Holders]
[--------------- FORM 8-K CURRENT REPORTte of Report (Date of earliest event reported): December 22, 2010 CHINA PHARMAS, --------------------------------------- Delaware 001-34471 73-1564807 (State or other jurisdiction (Commission File No.) (IRS Employer oforporation) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China570216 +86 898-6681-1730 Item 5.07.Submission of Matters to a Vote of Security Holders]
[SCHEDULE 14A INFORMATION þ o Check the appropriate box: o Preliminary Proxy Statement o 6(e)(2) ) o Definitive Proxy Statement þ Definitive Additional Materials o CHINA PHARMA HOLDINGS, INC. Payment of Filing Fee (Check the appropriate box): þ No fee required. o Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. (1)]
[SCHEDULE 14A INFORMATION þ o Check the appropriate box: o Preliminary Proxy Statement o þ Definitive Proxy Statement o Definitive Additional Materials o]
[SCHEDULE 14A INFORMATION þ o Check the appropriate box: o Preliminary Proxy Statement o þ Definitive Proxy Statement o Definitive Additional Materials o]
[SCHEDULE 14A INFORMATION o Check the appropriate box: o Preliminary Proxy Statement o Definitive Proxy Statement o Definitiveditional Materials o CHINA PHARMAS, Payment of Filing Fee (Check the appropriate box): o No fee required. o Feemputed on table below per Exchange Act Rules14a-6(i)(1) and 0-11. (1) Title of each class of securities to which transaction]
[SCHEDULE 14A INFORMATION o Check the appropriate box: o Preliminary Proxy Statement o 6(e)(2) ) o Definitive Proxy Statement Definitiveditional Materials o CHINA PHARMAS, Payment of Filing Fee (Check the appropriate box): No fee required. o Feemputed on table below per Exchange Act Rules14a-6(i)(1) and 0-11. (1)]
[SCHEDULE 14A INFORMATION o Check the appropriate box: o Preliminary Proxy Statement o Definitive Proxy Statement o Definitiveditional Materials o CHINA PHARMAS, Payment of Filing Fee (Check the appropriate box): o No fee required. o Feemputed on table below per Exchange Act Rules14a-6(i)(1) and 0-11. (1) Title of each class of securities to which transaction]
[FORM 10-Q (Mark One) x September 30, 2010 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Delaware 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) (Issuer's telephone number, including area code)] [Hainan Helpson Medical & Biotechnology Co., Ltd. Long-term Labor Contract Employer: Hainan Helpson Medical & Biotechnology Co., Ltd. (hereunder called Party A or Company) Zhilin Li Legal Representative/ authorised agent: Unit 8, D Area, Office Hall, Haikou Bonded Zone, Haikou Party A's address: 570216 Post Code: Zhilin Li (hereunder called Party B) Employee: Female Sex: 57 Age: Bachelor Education Level:] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: November 10, 2010 -------------------------------- President and Chief Executive Officer EX-32.1 5 cphi10qex321093010.htm] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: November 10, 2010 --------------------- (principal financial officer and principal accounting officer) EX-32.2 6 cphi10qex322093010.htm]
[FORM 10-Q (Mark One) x September 30, 2010 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Delaware 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) (Issuer's telephone number, including area code)] [Hainan Helpson Medical & Biotechnology Co., Ltd. Long-term Labor Contract Employer: Hainan Helpson Medical & Biotechnology Co., Ltd. (hereunder called Party A or Company) Zhilin Li Legal Representative/ authorised agent: Unit 8, D Area, Office Hall, Haikou Bonded Zone, Haikou Party A's address: 570216 Post Code: Zhilin Li (hereunder called Party B) Employee: Female Sex: 57 Age: Bachelor Education Level:] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: November 10, 2010 -------------------------------- President and Chief Executive Officer EX-32.1 5 cphi10qex321093010.htm] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: November 10, 2010 --------------------- (principal financial officer and principal accounting officer) EX-32.2 6 cphi10qex322093010.htm]
